Home / Fractyl Laboratories, Inc.

Changing the Treatment Paradigm in Metabolic Disease The REVITA-T2Di Study is evaluating a new treatment for people with type 2 diabetes that may eliminate or reduce insulin requirements Enroll Now Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. Our Mission Fractals appear all throughout nature. They are self-repeating patterns in plants, animals, rivers, mountains, coastlines, and even clouds – all seemingly complex structures that are, in fact, fundamentally quite simple at their base. To ...Read more